Sergio Dastis-Negrin
Charleroi, WAL, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Clinical Trial: Hepatitis B Virus Genotype and a Combination of End-of-Treatment Biomarkers Predict Severe Flares After Nucleos(t)ide Analogue Cessation.
Journal: Alimentary pharmacology & therapeutics
Published: September 04, 2025
Co-existing regeneration mechanisms in severe alcohol-related steatohepatitis.
Journal: Translational gastroenterology and hepatology
Published: July 16, 2024
Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agents.
Journal: Acta gastro-enterologica Belgica
Published: February 28, 2021
Cholestatic hepatitis after diagnostic ajmaline challenge.
Journal: Acta gastro-enterologica Belgica
Published: March 22, 2018
Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes.
Journal: Alimentary pharmacology & therapeutics
Published: September 14, 2017
Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium.
Journal: PloS one
Published: October 05, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026